Evogene (NYSE: EVGN) reported Q1 EPS of ($0.13), versus ($0.13) reported last year. Revenue for the quarter came in at $2 million, versus $2.7 million reported last year.

For earnings history and earnings-related data on Evogene (EVGN) click here.